Replimune Group, Inc. (REPL)
Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 20260 patents granted to the name below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Replimune Group, Inc.’s names, not what it holds today.
16 published
| Published | Application | Title | Field | Owner as printed |
|---|---|---|---|---|
| Nov 20, 2025 | 2025/0352646 | ENGINEERED VIRUS | Pharmaceuticals | Replimune Limited |
| Oct 31, 2024 | 2024/0358781 | ALTERED VIRUS | Pharmaceuticals | Replimune Limited |
| Sep 12, 2024 | 2024/0301365 | ONCOLYTIC VIRUS STRAIN | Pharmaceuticals | Replimune Limited |
| Jan 18, 2024 | 2024/0018488 | MODIFIED ONCOLYTIC VIRUS | Pharmaceuticals | Replimune Limited · patent 12,465,639 granted from it |
| Jul 6, 2023 | 2023/0212531 | ENGINEERED VIRUS | Pharmaceuticals | Replimune Limited · patent 12,397,053 granted from it |
| Jun 29, 2023 | 2023/0203453 | MODIFIED ONCOLYTIC VIRUS | Pharmaceuticals | Replimune Limited · patent 12,458,696 granted from it |
| Apr 27, 2023 | 2023/0130992 | ONCOLYTIC VIRUS STRAIN | Pharmaceuticals | Replimune Limited · patent 12,024,724 granted from it |
| Aug 19, 2021 | 2021/0254019 | ENGINEERED VIRUS | Pharmaceuticals | Replimune Limited · patent 12,049,647 granted from it |
| Aug 19, 2021 | 2021/0252135 | TREATMENT USING ONCOLYTIC VIRUS | Pharmaceuticals | Replimune Limited |
| Jul 2, 2020 | 2020/0208122 | ONCOLYTIC VIRUS STRAIN | Pharmaceuticals | Replimune Limited · patent 11,473,063 granted from it |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.